Vestal Point Capital »

Galapagos Nv- shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Galapagos Nv- (GLPG) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Galapagos Nv-

Tip: Access up to 7 years of quarterly data

All positions including Galapagos Nv- held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galapagos Nv- by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.5M 180k 24.78

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Galapagos Nv-

EcoR1 Capital
FMR
BVF
Deerfield Management Company
Prosight Management
Segall Bryant & Hamill
PRIMECAP Management Company
BlackRock
Hudson Bay Capital Management
Finepoint Capital
Newtyn Management
Stonepine Capital Management
Wellington Management Company
Millennium Management
Renaissance Technologies

View all funds holding Galapagos Nv-